Introduction:
H3N2 influenza and COVID-19 are both respiratory illnesses. The causative agent for H3N2 influenza is the influenza A virus, while COVID-19 is caused by the SARS-CoV-2 virus. This article explores the relationship between H3N2 influenza and COVID-19. The article will cover similarities and differences between the two illnesses, the risk of co-infection, and the impact of the COVID-19 pandemic on seasonal influenza.
What Is H3N2 Influenza?
H3N2 influenza is a type of influenza A virus that causes seasonal flu outbreaks every year. The virus is named after two major surface proteins, hemagglutinin (H) and neuraminidase (N). H3N2 is the most common strain of influenza virus that circulates in humans and is responsible for significant flu-related illnesses and deaths each year. H3N2 influenza is a respiratory illness spread through droplets of an infected person when he coughs, sneezes, or talks. Symptoms of H3N2 influenza can include fever, cough, sore throat, body aches, headache, and fatigue. While most people recover from H3N2 influenza without complications, it can lead to severe illness and even death in some cases, especially in young children, the elderly, and people with severe health conditions.
It is diagnosed through the patient's medical history, signs and symptoms, and laboratory testing. Lab tests include:
-
PCR (Polymerase Chain Reactions): Swabs are collected from the nose or throat to detect the presence of a virus.
-
Rapid Influenza Diagnostic Test (RIDT): It involves taking a swab of the nose or throat to detect the presence of the influenza virus. Results from an RIDT can be available within 15 to 30 minutes. However, RIDTs are not as accurate as other tests, such as PCR (polymerase chain reaction) tests, and may produce false-negative results in some cases.
What Are the Treatment Options for H3N2?
The treatment for H3N2 influenza typically involves a combination of antiviral medications and supportive care.
-
Medications: Antiviral medications like, Oseltamivir and San movie Zanamivir are effective in the treatment of H3N2 influenza if they are started within 48 hours of the onset of symptoms. These medications stop or slow down the replication of the virus and help to reduce the severity and duration of symptoms and avoid the risk of complications.
-
Supportive Care: It may include rest, drinking plenty of water, and over-the-counter medications to relieve symptoms such as fever and pain. In some cases, individuals with severe H3N2 infections may require hospitalization for more intensive care, such as oxygen therapy or mechanical ventilation.
Antibiotics are not the choice in treating H3N2 influenza, as it is caused by a virus rather than a bacterial infection. However, if antibiotics are prescribed, there may be a bacterial infection, such as pneumonia, which is a common complication of the flu. Various preventive measures are available such as getting vaccinated against the flu, maintaining hand hygiene, and avoiding close contact with sick individuals are the best ways to reduce the risk of getting H3N2 influenza.
What Is COVID-19?
COVID-19 is a highly infectious respiratory illness caused by the SARS-CoV-2 virus. It was first identified in Wuhan, China, in December 2019 and has since become a global pandemic. It is a new disease. COVID-19 is also a respiratory illness like H2N3 influenza. COVID-19 is transmitted from one person to another through talking, sneezing, or coughing through respiratory droplets. Symptoms include fever, cough, shortness of breath, fatigue, body aches, headache, lack of taste or smell, and sore throat. COVID-19 can range from mild to severe illness and be fatal, particularly in older adults and people with underlying health conditions.
For diagnosis, the doctor will look for physical signs and symptoms and recommend the following tests:
-
PCR (Polymerase Chain Reaction) Test: It is the most common test, which involves taking a swab of the nose or throat to detect the presence of the SARS-CoV-2 virus. Results from a PCR test typically take a few days to come back.
-
Rapid Antigen Tests: They can provide results in 15 minutes. However, these tests are generally less accurate than PCR tests and may produce false-negative results in some cases.
-
Serology Tests: It detects antibodies to the virus in the blood. However, these tests are used to determine if the patient has been previously infected with the virus.
What Are the Treatment Options for COVID-19?
The treatment for COVID-19 varies depending on the severity of the illness.
-
Mild to Moderate Cases: For mild to moderate cases can often be managed with supportive care, such as rest, hydration, and over-the-counter medications to relieve symptoms like fever and cough.
-
Severe Cases: Hospitalization may be necessary, and treatment may involve oxygen therapy, and mechanical ventilation, along with the use of antiviral medications like Remdesivir, which can reduce the duration of hospitalization for some cases.
Along with supportive care and antiviral medications, monoclonal antibody treatments are also available for certain high-risk individuals with mild to moderate COVID-19. These treatments can reduce the risk of hospitalization and severe illness in some patients. Several vaccines are available that are effective in preventing severe illness and hospitalization from COVID-19. Vaccines are recommended for everyone eligible and able to receive them, and vaccine availability and distribution vary by country. There is no treatment for COVID-19, but follow basic public health guidelines such as wearing masks, washing hands frequently, practicing physical distancing, and getting vaccinated.
Is Co-Infection a Main Concern Associated With H3N2 Influenza and COVID-19?
One concern associated with H3N2 influenza and COVID-19 is the risk of co-infection. While it is possible to have both H3N2 influenza and COVID-19 at the same time, it is unclear how common co-infection is and whether it leads to more severe illness. However, co-infection could increase the risk of complications and make it more difficult to treat both illnesses.
The COVID-19 pandemic substantially impacts seasonal influenza. In Australia and New Zealand, the number of influenza cases during 2020 was much lower than in previous years, which is due to the preventive measures taken to limit the spread of COVID-19, such as physical distancing and mask-wearing. However, the effectiveness of the influenza vaccine and the severity of the influenza season can vary from year to year.
Is There Any Relationship Between H3N2 Influenza and Covid-19 Virus?
There is no direct relationship between the two viruses, but both COVID-19 and the H3N2 influenza virus share similarities; they primarily spread when an infected person talks, coughs, or sneezes. The symptoms of both illnesses can occur from mild to severe, and sometimes, they can be fatal, particularly in vulnerable populations such as the elderly, immunocompromised individuals, and those with underlying health conditions. Hygienic habits like washing hands regularly, wearing masks, social distancing, and avoiding crowded places are effective in reducing the spread of both the COVID-19 and the H3N2 influenza viruses.
What Are the Differences?
Differences are as follows:
COVID-19 occur by a novel Coronavirus (SARS-CoV-2) that emerged in late 2019, while the H3N2 influenza virus is a type of influenza virus that has been circulating for many years. COVID-19 has a higher overall mortality rate than the H3N2 influenza virus, but the severity of the illness can vary widely between individuals. COVID-19 can cause a broader range of symptoms, including fever, cough, shortness of breath, fatigue, lack of taste or smell, and body pains, while the H3N2 influenza virus typically causes fever, cough, sore throat, runny or stuffy nose, body pain, and fatigue. The vaccines and treatments for COVID-19 and H3N2 influenza viruses are different, with COVID-19 vaccines and treatments being developed specifically for the SARS-CoV-2 virus, while the influenza vaccine and antiviral medications are tailored to target the different strains of influenza viruses that are in circulation each year.
Conclusion:
While H3N2 influenza and COVID-19 are caused by different viruses, they are both respiratory illnesses that can cause similar symptoms and are spread through respiratory droplets. While both illnesses can occur at the same time, it is unclear how common co-infection is and whether it leads to a more severe illness. The effect of the COVID-19 pandemic on seasonal influenza is debated, but it is unclear whether this trend will continue in future influenza seasons. As with COVID-19, the best way to prevent the spread of H3N2 influenza is to practice good hand hygiene, wear a mask, and practice physical distancing.
